Cargando…
Corrigendum: A Two-Year Treatment of Amnestic Mild Cognitive Impairment using a Compound Chinese Medicine: A Placebo Controlled Randomized Trial
Autores principales: | Zhang, Junying, Liu, Zhen, Zhang, Huamin, Yang, Caishui, Li, He, Li, Xin, Chen, Kewei, Zhang, Zhanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991282/ https://www.ncbi.nlm.nih.gov/pubmed/27541385 http://dx.doi.org/10.1038/srep30511 |
Ejemplares similares
-
A Two-Year Treatment of Amnestic Mild Cognitive Impairment using a Compound Chinese Medicine: A Placebo Controlled Randomized Trail
por: Zhang, Junying, et al.
Publicado: (2016) -
Multistage Grading of Amnestic Mild Cognitive Impairment: The Associated Brain Gray Matter Volume and Cognitive Behavior Characterization
por: Yang, Caishui, et al.
Publicado: (2017) -
Hippocampus-centred grey matter covariance networks predict the development and reversion of mild cognitive impairment
por: Dang, Mingxi, et al.
Publicado: (2023) -
Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
por: Rubin, David T, et al.
Publicado: (2017) -
Corrigendum: In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database
por: Dai, Shao-Xing, et al.
Publicado: (2016)